<DOC>
	<DOCNO>NCT01397721</DOCNO>
	<brief_summary>The Multi-Ethnic Study Atherosclerosis ( MESA ) - Chronic Obstructive Pulmonary Disease ( COPD ) Study aim characterize pulmonary vascular change biology early COPD use imaging , gene expression profile peripheral cellular measure .</brief_summary>
	<brief_title>Pulmonary Vascular Changes Early Chronic Obstructive Pulmonary</brief_title>
	<detailed_description>Chronic Obstructive Pulmonary Disease ( COPD ) third lead cause death US soon replace stroke third lead cause . Translation promise biological hypothesis COPD pathogenesis human population may lead new therapy urgently need . The vascular hypothesis COPD articulate almost 50 year ago . Bench research endothelial dysfunction COPD evolve rapidly show acrolein cigarette smoke cause endothelial apoptosis endothelial apoptosis directly implicate COPD pathogenesis . Clinical study endothelial dysfunction vascular change COPD limit . The propose study longitudinal study smoker nest among MESA-Lung ( AAAA7791 ) EMphysema Cancer Action Project ( EMCAP ) Studies ( AAAA6484 ) , together provide well-defined cohort 4,617 participant prior spirometry CT measure . The Multiethnic Study Atherosclerosis - Chronic Obstructive Pulmonary Disease ( MESA COPD Study ) two main scientific purpose : 1. characterize pulmonary vascular change COPD biology , 2. propose novel pathways new therapy COPD . MESA COPD longitudinal study smoker nest within MESA-Lung EMCAP cohorts 360 participant ( 160 case mild , 60 case moderate 40 case severe COPD 100 control ) phenotyped magnetic resonance ( MR ) pulmonary angiography , pulmonary function test , full-lung CT scan , serum Vascular Endothelial Growth Factor ( VEGF ) , cell assay gene expression profile . MESA COPD Study contribute improve knowledge early change COPD may lead novel disease-modifying medical therapy preventative strategy .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>age 5079 year time enrollment ever smoker ( 10 packyears ) participation MESA EMCAP study clinical cardiovascular disease ( left congestive heart failure ( CHF ) , valve disease , coronary artery disease ( CAD ) , stroke , congenital heart disease ) , asthma , pulmonary embolism lung disease COPD , weight &gt; 300 lb , chronic renal insufficiency ( [ estimate glomerular filtration rate ( eGFR ) ] &lt; 45 mL/min/1.73 m2 ) , cancer , atrial fibrillation , contraindication magnetic resonance imagine ( MRI ) , gadolinium , albuterol spirometry test .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease ( COPD )</keyword>
	<keyword>pulmonary vasculature</keyword>
	<keyword>pulmonary hypertension</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>smoker</keyword>
	<keyword>emphysema</keyword>
</DOC>